Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.
2.

Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays.

Chugh P, Tamburro K, Dittmer DP.

J Vis Exp. 2010 Dec 3;(46). pii: 2210. doi: 10.3791/2210.

3.

Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.

Haecker I, Gay LA, Yang Y, Hu J, Morse AM, McIntyre LM, Renne R.

PLoS Pathog. 2012;8(8):e1002884. doi: 10.1371/journal.ppat.1002884. Epub 2012 Aug 23. Erratum in: PLoS Pathog. 2013 Mar;9(3). doi: 10.1371/annotation/bb6f7450-8506-41c3-8519-020df8b382b9.

4.

The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.

Albonico F, Mortarino M, Avallone G, Gioia G, Comazzi S, Roccabianca P.

Vet Immunol Immunopathol. 2013 Sep 1;155(1-2):117-23. doi: 10.1016/j.vetimm.2013.06.018. Epub 2013 Jul 3.

PMID:
23871213
5.

MicroRNA expression profiling of male breast cancer.

Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A.

Breast Cancer Res. 2009;11(4):R58. doi: 10.1186/bcr2348. Epub 2009 Aug 10.

6.

Alterations of mRNA splicing in primary effusion lymphomas.

Li Z, Pan L, Cesarman E, Knowles DM.

Leuk Lymphoma. 2003 May;44(5):833-40.

PMID:
12802923
7.

Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.

Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC, Robetorye RS, Aguiar RC.

Blood. 2009 Jun 25;113(26):6681-90. doi: 10.1182/blood-2009-01-202028. Epub 2009 Mar 10.

8.

Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.

Plieskatt JL, Rinaldi G, Feng Y, Levine PH, Easley S, Martinez E, Hashmi S, Sadeghi N, Brindley PJ, Bethony JM, Mulvenna JP.

J Transl Med. 2014 Jan 6;12:3. doi: 10.1186/1479-5876-12-3.

9.

MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.

Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G, Renner C, Grässer FA.

PLoS One. 2012;7(8):e42193. doi: 10.1371/journal.pone.0042193. Epub 2012 Aug 3.

10.

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15732-7. doi: 10.1073/pnas.0906947106. Epub 2009 Aug 24.

11.

A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.

Fassina A, Cappellesso R, Simonato F, Siri M, Ventura L, Tosato F, Busund LT, Pelizzo MR, Fassan M.

Cancer Cytopathol. 2014 Apr;122(4):274-81. doi: 10.1002/cncy.21383. Epub 2013 Dec 10.

12.

Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155.

Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R.

J Virol. 2007 Dec;81(23):12836-45. Epub 2007 Sep 19.

13.

MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.

Hother C, Rasmussen PK, Joshi T, Reker D, Ralfkiær U, Workman CT, Heegaard S, Ralfkiær E, Grønbæk K.

Invest Ophthalmol Vis Sci. 2013 Aug 5;54(8):5169-75. doi: 10.1167/iovs.13-12272.

PMID:
23821202
14.

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, Sotomayor E, Tao J, Cheng JQ.

Blood. 2010 Apr 1;115(13):2630-9. doi: 10.1182/blood-2009-09-243147. Epub 2010 Jan 19.

15.

In-depth characterization of the microRNA transcriptome in a leukemia progression model.

Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, Heuser M, Yung E, Piper J, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Hansen CL, Marra MA, Humphries RK.

Genome Res. 2008 Nov;18(11):1787-97. doi: 10.1101/gr.077578.108. Epub 2008 Oct 10.

16.

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M.

Am J Pathol. 2012 May;180(5):1808-15. doi: 10.1016/j.ajpath.2012.01.034. Epub 2012 Mar 15.

PMID:
22426337
17.

Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.

Willenbrock K, Küppers R, Renné C, Brune V, Eckerle S, Weidmann E, Bräuninger A, Hansmann ML.

Haematologica. 2006 May;91(5):596-604.

18.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
19.

Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors.

Lee EJ, Baek M, Gusev Y, Brackett DJ, Nuovo GJ, Schmittgen TD.

RNA. 2008 Jan;14(1):35-42. Epub 2007 Nov 19.

20.

A high-throughput method to monitor the expression of microRNA precursors.

Schmittgen TD, Jiang J, Liu Q, Yang L.

Nucleic Acids Res. 2004 Feb 25;32(4):e43.

Supplemental Content

Support Center